POMDOCTOR LIMITED (POM) vs AsiaStrategy (SORA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
AsiaStrategy is the larger company by market cap ($52.2 million vs $7.8 million), about 6.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | POM | SORA |
|---|---|---|
| Share price | $0.8384 | $2.10 |
| Market cap | $7.77M | $52.22M |
| 1-day change | -1.23% | +0.48% |
| YTD return | — | -31.48% |
| 1-year return | — | -59.81% |
| P/E ratio (TTM) | — | 4.20 |
| EPS (TTM) | $-6.84 | $0.50 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $115.74 | $6.60 |
| 52-week low | $0.50 | $1.25 |
| Distance from 52-week high | -99.28% | -68.18% |
| Average volume | 64.74K | 213.43K |
| Shares outstanding | 8.59M | 24.86M |
| Sector | Consumer Discretionary | Industrials |
| Industry | Other Specialty Stores | Other Specialty Stores |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- AsiaStrategy is about 6.7 times larger than POMDOCTOR LIMITED by market value ($52.22M vs $7.77M).
- The two companies sit in different sectors: POMDOCTOR LIMITED in Consumer Discretionary and AsiaStrategy in Industrials.
POM vs SORA FAQ
Which is bigger, POMDOCTOR LIMITED or AsiaStrategy?
AsiaStrategy (SORA) is larger, with a market capitalization of $52.22M compared with $7.77M for POMDOCTOR LIMITED (POM).
Are POMDOCTOR LIMITED and AsiaStrategy in the same industry?
Yes. Both are classified in the Other Specialty Stores industry within the Consumer Discretionary sector.